Outcome and characteristics of patients with advanced gynaecological malignancies enrolled in phase I trials

被引：0
|
作者：
Rouge, T. de La Motte [1 ]
Roca, C. Gomez [1 ]
Bahleda, R. [1 ]
Gombos, A. [1 ]
Pautier, P. [1 ]
Soria, J. C. [1 ]
Lhomme, C. [1 ]
Massard, C. [1 ]
机构：
[1] Inst Gustave Roussy, Villejuif, France
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：136 / 136
页数：1
相关论文
共 50 条
  • [21] Clinical outcome for patients with metastatic colorectal cancer (mCRC) enrolled in phase I clinical trials: Single institution experience
    Shah, Umang
    Pendurti, Gopichand
    Swami, Umang
    Hou, Yijuan
    Ghalib, Mohammad Haroon
    Chaudhary, Imran
    Mani, Sridhar
    Goel, Sanjay
    Aparo, Santiago
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] Clonal hematopoiesis (CH) associated mutations in patients with advanced solid tumors enrolled in phase I clinical trials.
    Rodriguez, Julieta
    Bayle, Arnaud
    Pages, Arnaud
    Danlos, Francois-Xavier
    Vasseur, Damien
    Rouleau, Etienne
    Lacroix, Ludovic
    De Castro, Beatriz Alonso
    Goldschmidt, Vincent
    Seknazi, Lauren
    Hollebecque, Antoine
    Michot, Jean-Marie
    Champiat, Stephane
    Marabelle, Aurelien
    Ouali, Kaissa
    Marzac, Christophe
    Aix, Santiago Ponce
    Italiano, Antoine
    Micol, Jean Baptiste
    Baldini, Capucine
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [23] Predictors of early treatment discontinuation in patients enrolled on Phase I oncology trials
    Hyman, David M.
    Eaton, Anne A.
    Gounder, Mrinal M.
    Pamer, Erika G.
    Pettiford, Jasmine
    Carvajal, Richard D.
    Ivy, S. Percy
    Iasonos, Alexia
    Spriggs, David R.
    ONCOTARGET, 2015, 6 (22) : 19316 - 19327
  • [24] MOSCATO: a Molecular Screening Triage Trial for Patients Enrolled in Phase I Trials
    Massard, C.
    Auger, N.
    Vielh, P.
    Lacroix, L.
    Lazar, V.
    Ngocamus, M.
    Le Deley, M. C.
    Andre, F.
    DeBaere, T.
    Soria, J. C.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 188 - 189
  • [25] A PHASE-I STUDY OF SWAINSONINE IN PATIENTS WITH ADVANCED MALIGNANCIES
    GOSS, PE
    BAPTISTE, J
    FERNANDES, B
    BAKER, M
    DENNIS, JW
    CANCER RESEARCH, 1994, 54 (06) : 1450 - 1457
  • [26] Gemcitabine and vinorelbine, a phase I study in patients with advanced malignancies
    Chaouche, M
    Delord, JP
    Raymond, E
    Vayre, L
    Ducreux, M
    Ruffle, P
    Rodier, JM
    Armand, JP
    ANNALS OF ONCOLOGY, 1998, 9 : 165 - 165
  • [27] A phase I study of sirolimus and bevacizumab in patients with advanced malignancies
    Cohen, E. E. W.
    Sharma, M. R.
    Janisch, L.
    Llobrera, M.
    House, L.
    Wu, K.
    Ramirez, J.
    Fleming, G. F.
    Stadler, W. M.
    Ratain, M. J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (10) : 1484 - 1489
  • [28] Phase I study of Doxil® and vinorelbine in patients with advanced malignancies
    Laufman, LR
    Spiridonidis, CH
    Jones, JJ
    Rhodes, V
    Rossi, K
    Wallace, K
    CANCER INVESTIGATION, 2004, 22 (03) : 344 - 352
  • [29] Phase I study of rubitecan and gemcitabine in patients with advanced malignancies
    Fracasso, PM
    Rader, JS
    Govindan, R
    Herzog, TJ
    Arquette, MA
    Denes, A
    Mutch, DG
    Picus, J
    Tan, BR
    Fears, CL
    Goodner, SA
    Sun, SL
    ANNALS OF ONCOLOGY, 2002, 13 (11) : 1819 - 1825
  • [30] CLINICAL CHARACTERISTICS AND OUTCOMES OF PEDIATRIC ONCOLOGY PATIENTS WITH AGGRESSIVE BIOLOGY ENROLLED IN PHASE I CLINICAL TRIALS DESIGNED FOR ADULTS
    Corrales-Medina, Fernando
    Herzog, Cynthia
    Egas-Bejar, Daniela
    Hess, Kennet
    Huh, Winston
    Anderson, Peter
    Hong, David
    Nunez, Cesar
    Kleinerman, Eugene
    Kurzrock, Razelle
    Subbiah, Vivek
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S93 - S93
12345